National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$44.00
add to cart

Rights & Permissions

topleft topright

Preserving Public Trust: Accreditation and Human Research Participant Protection Programs (2001)
Institute of Medicine (IOM)

Citation Manager

. "References." Preserving Public Trust: Accreditation and Human Research Participant Protection Programs. Washington, DC: The National Academies Press, 2001.

Please select a format:

BibTeX EndNote RefMan


Page
102
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Preserving Public Trust: Accreditation and Human Research Participant Protection Programs

Rudder, Catherine (Executive Director, American Political Science Association). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.

Ryan, Stephen J. (Dean, Keck School of Medicine, University of Southern California). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.

Shalala, Donna. 2000. Sounding Board: Protecting Research Subjects—What Must Be Done. New England Journal of Medicine 343:808–810.

Shopes, Linda (Historian, Pennsylvania Historical and Museum Commission). 2001. Written comments to the Institute of Medicine Committee on Assessing the System for Protecting Human Research Subjects.

Snyderman, R., and Holmes E. W. 2000. Oversight Mechanisms for Clinical Research. Science 287:595–597.

Starr, Paul. 1982. Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry. New York: Basic Books.

Sugarman, J. 2000. The Role of Institutional Support in Protecting Human Research Subjects Academic Medicine 75:687–692.

Thompson, Larry. 1994. Correcting the Code: Inventing the Genetic Cure for the Human Body . New York: Simon and Schuster.

Tuskegee Syphilis Study Ad Hoc Advisory Panel. 1973. Final Report. Washington, DC: U.S. Department of Health, Education, and Welfare.

United States v. Karl Brandt et al. 1949. In: The Medical Case, Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10. Washington, DC: U.S. Government Printing Office.

U.S. House of Representatives, Committee on Veterans Affairs. 1999. Suspension of Medical Research at West Los Angeles and Sepulveda VA Medical Facilities and Informed Consent and Patient Safety in VA Medical Research: Hearing of the Committee on Veterans Affairs. 106th Cong. April 21, 1999.

U.S. Senate, Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions. 2000. Gene Therapy: Is There Oversight for Patient Safety?: Hearing of the Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions. 106th Congress. February 2, 2000.

VA (U.S. Department of Veterans Affairs). 2000. Press Release: VA Raises Standard for Protecting Human Research Participants . [Online]. Available: http://www.va.gov/opa [accessed February 20, 2001].

Weiss, R. and Nelson, D. 1999, December 8. Methods Faulted in Fatal Gene Therapy. The Washington Post. p. A1.

World Medical Association. 1964. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Ferney-Voltaire, France: World Medical Association.

World Medical Association. 2000. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects, revised. Ferney-Voltaire, France: World Medical Association.

Young, Kenneth E., Chamber, Charles M., Kells, H. R., and Associates. 1983. Understanding Accreditation. San Francisco: Jossey-Bank, Inc.

Page
102